Cancer remains one of the leading causes of morbidity and mortality worldwide, despite significant advances in molecular biology, targeted therapy, and ...
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...
A multicenter research effort yielded findings that may allow for more effective and personalized treatment of an underrecognized but serious blood disorder.Extended follow-up of individuals with ...
Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...
If you used talc as a child, or still use it now, here’s what the science says about the link with cancer. It might not be ...
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...
Women with metastatic breast cancer often face multiple chronic conditions, and high blood pressure is among the most common.
Thanks to modern therapies, a cancer diagnosis is no longer an automatic death sentence. But many patients still suffer from ...
After decades, scientists have finally pieced together the 23-step biosynthetic pathway to produce this cancer drug ...
The National Cancer Institute, the federal research agency charged with leading the war against the nation’s second-largest killer, is studying ivermectin as a potential cancer treatment, according to ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...
Share on Pinterest A follow-up study indicates that aspirin should not be recommended to older adults for cancer prevention. Image credit: Yulia Naumenko/Getty Images A new study suggests that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results